UPDATE 1-Novo Nordisk, Baxter clash over haemophilia drug patent
May 20, 2015 at 12:08 PM EDT
COPENHAGEN, May 20 (Reuters) - Novo Nordisk on Wednesday rejected claims by Baxter International that its drug used substances developed by the U.S. rival, following the launch this week of a U.S. investigation into possible patent infringement.
